Kane Biotech Inc. (KNE.V)
TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
At close: 11:24AM EST
Show:
Annual
Income Statement
All numbers in thousandsBreakdown
ttm
2020-12-31
2019-12-31
2018-12-31
2017-12-31
Total Revenue
1,453
1,342
1,694
506.273
1,035
Cost of Revenue
969.578
814.715
1,084
390.802
122.403
Gross Profit
483.842
526.859
609.912
115.471
912.899
Operating Expenses
Research Development
1,100
1,326
1,541
922.526
850.578
Selling General and Administrative
4,030
3,425
2,659
2,372
2,757
Total Operating Expenses
5,130
4,751
4,200
3,294
3,608
Operating Income or Loss
-4,646
-4,224
-3,590
-3,179
-2,695
Interest Expense
377.871
121.556
141.675
89.777
90.758
Total Other Income/Expenses Net
351.811
461.653
2,771
-2.01
-16.346
Income Before Tax
-4,539
-3,846
-960.178
-3,261
-2,786
Income from Continuing Operations
-4,539
-3,846
-960.178
-3,261
-2,786
Net Income
-4,152
-3,717
-960.178
-3,261
-2,786
Net Income available to common shareholders
-4,152
-3,717
-960.178
-3,261
-2,786
Basic EPS
-
-0.03
-0.01
-0.04
-0.05
Diluted EPS
-
-0.03
-0.01
-0.04
-0.05
Basic Average Shares
-
107,549
101,532
80,114
61,283
Diluted Average Shares
-
107,549
101,532
80,114
61,283
EBITDA
-
-3,646
-764.079
-3,099
-2,626
